BIOTRONIK Neuro today announced the launch of Embrace One® Proactive Intelligence, a proprietary AI capability that advances ...
Medical Device Network on MSN
BIOTRONIK Neuro acquires Soin Neuroscience’s SCS IP portfolio
The acquisition follows a previous research collaboration between Soin Neuroscience and BIOTRONIK Neuro in December 2025.
Spinal cord stimulation (SCS) to treat pain in persons with multiple sclerosis (MS) was the focus of a recent literature review out of Italy. An analysis from Italy of 7 studies that investigated ...
Soin Neuroscience announced today that it sold intellectual property related to spinal cord stimulation (SCS) to Biotronik Neuro.
Medical Device Network on MSN
NHS Trust completes UK’s first SCS implant in adolescent patient
Upon completion of the SCS neuromodulation implant procedure, the chronic pain 18-year-old Ralph Seed had experienced for the ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”), a Carlsbad, California-based neurostimulation company that has miniaturized neurostimulation implants for the management of chronic ...
Abbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS) system for treating chronic pain. The Eterna SCS system is the smallest implantable, rechargeable ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc (“Nalu”) is a Carlsbad, California-based company that has successfully miniaturized neurostimulation implants for the management of chronic ...
Boston Scientific, Inc. BSX recently received FDA approval for an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (“SCS”) Systems. With this approval, the system will be available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results